ÃâÒßѧÊÔÌâ
f`rI]v|@ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
2B)1
tP 1. Fas(CD95)/FasL
OXl0R{4 2. common chain of cytokine receptor
Z<=L 3 . TCR/CD3 complex
0k_3]Li=( 4. negaive selection of thymocytes
<EE^ KR96 5. artificial active immune
-s)h
?D 6. anti-idiotypic
PQ;9iv 7. IgSF
+BhJske 8. Integrin
B\aVE|~PB 9. chemokine
UxF9Ko( ]d 10. B7/CD28
GjN6Af~} ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
(!efaj 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
QX&Y6CC`] 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
~>_UTI 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
#Jp|Cb<qx 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
.r-
Zz3
&sYxe:H 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
?'H+u[1. µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
mQSn*;9\T3 Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
@J qo'\~& 1. B7/CD28
iweT@P` 2. Th1 subset
O.\\)8xA 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
19[!9ci 4. antibody affinity maturation
Bva2f:)K| 5. AP-1
o=Mm=;H 6. single chain variable fragment£¨ScFv£©
l,3,$ 7. NK cell receptor
62Tel4u 8. Zinkernagel-Doherty phenomenon
3Of!Ykf= 9. Ig fold
yh|+Usa 10. CD40/CD40L
1;B&R89} ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
Bu?Qyz2O 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
!mB
`F C
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
Br{(sL0e 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
>pJ#b= Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
a0 PU&o1EF 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
@6aJh< c 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
Fq
oh!F 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
} *C Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
EQw7(r|v: £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
]ZW-`U MO Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
O?"uM >r 1.Co-stimulators (or co-stimulating molecules)
7xux%:BN 2.NK-kB
.=d40m 3.Immunoglobulin superfamily
@de0)AJG6 4.antigen-presenting cell (APC)
d+ZXi' 5.death domain
EwuRIe;D 6.CCR and CXCR
Q"c/]Sk) 7.Lectin (or mitogen)
~t$ng l$ 8.Clusters of differentiation, CD)
n6M #Xc'JA 9.B7 family
)`ixT) 10.Cytotoxic T lymphocyte, CTL)
,S<) ) 11.IL-15 and IL-15 receptor (IL-15R)
#Q-#7|0& 12.MHC restriction
=YfzB!ld 13.Affinity-chromatography
njO~^Hl7 14.Cyctosprin A, CsA
%B1)m A; 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
H Vhd#Q; ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
Qb55q`'z 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
r ?<kWR?w 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
o2hZ=+w> 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
A"s?;hv\fS Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
nt-_)4Fm ÃâÒßѧרҵ£º
YktZXc?iI< 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
F< 5kcu#iL Ïû»¯ÄÚ¿Æ£º
.XRe:\8mc 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
YjJ^SU`* ѪҺ²¡Ñ§×¨Òµ£º
V[]Pya|s+ 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
UUZm]G+ Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
o:"(\$ (רҵ»ù´¡: ÃâÒßѧ)
NXDkGO/* Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
V"2 G 1. ADCC(antibody dependent cell-mediated cytotoxicity)
bb\XZ~)F 2. »·æß¾úËØ(cyclosporin)
`
"-P g5 3. KIR(killer cell inhibitory receptor)
]@Z
nP,8 4. HLDA(human leucocyte differentiation antigen)
vWrTB 5. Interleukin 18(IL-18)
UJ%.KU%Q} 6. ÕûºÏËØ(integrin)
^,vFxN--q 7. Fas/FasL
(: kn) 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
v6Y[_1 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
9HiyN>( 10. Th1/Th2
Q=vo5)t 11. »ùÒòÒßÃç(DNAÒßÃç)
d)D!np= 12. chemokines and chemokine receptor
9IrCu?n9b 13. ÃâÒßÄÍÊÜ
YGs'[On8 14. ¹²´Ì¼¤·Ö×Ó
}NGP! 15. ËÀÍö½á¹¹Óò(death domain)
*b0z/6 ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
F
0zaA 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
(4yXr|to} 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
sKR%YK
"A £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
vkR~nIp £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
Cc`-34/% £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
jTV4iX £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
@W
@,8e]c 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
0raFb,6l Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
9kqR-T|Q ÎÊ´ðÌâ(ÿÌâ25·Ö)
;~[}B v 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
q *Hg-J} 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
{YrA[9 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
-wl&~}%M 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£